Connect with us

Hi, what are you looking for?

Jewish Business News


China’s XIO Group acquires Israeli Lumenis for $510 million

XIO is paying a 16% premium on the share price of the Israeli medical device company.


Lumenis Ltd. (Nasdaq:LMNS), was acquired by Chinese investment fund XIO Group for $14.00 per share in cash, for an aggregate purchase price of approximately $510 million.

Israel based Lumenis medical company focuses on surgical, ophthalmology and aesthetic applications.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

“This acquisition is a strong recognition and vote of confidence in Lumenis’ achievements and its employees, and I am excited about the future prospects of Lumenis, ” said Tzipi Ozer-Armon, Chief Executive Officer. “Over the past 3 years we have managed to transform Lumenis into a strong, growing and profitable company. We have refocused our strategy, introduced new products, and tripled our EBITDA. Furthermore, we have created a very bright and promising future for Lumenis by building a robust pipeline of innovative products, a strong sales team in each region, and by enhancing our global brand recognition. I am confident that we will continue to thrive and reach new heights together with XIO Group.”

The Board of Directors of each of Lumenis and XIO Group has approved the transaction and is expected to close in September 2015.

The two largest shareholders of Lumenis, Viola Group and XT Hi-Tech Investments (1992) Ltd., which collectively own approximately 59% of the shares of Lumenis, have entered into a customary voting agreement with XIO Group.

Goldman Sachs acted as the exclusive financial advisor to Lumenis in respect of this transaction. Morgan Stanley acted as the exclusive financial advisor to XIO Group.


– The cosmetic laser company raised $75 million, below the $100 million it sought. – – / By Shmulik Shelach and Tali Tsipori / Lumenis Ltd. raised a gross $75 million in its IPO on Nasdaq, in its return More…


By Ilan Shavit On Sunday, February 16th, 2014

Israeli Medical Laser Co Lumenis Set to Raise $100 Million on Nasdaq

– The company is returning to Nasdaq after delisting in 2005. – – The Yokneam-based company Lumenis Ltd. announced that it is set to raise $100 million on the Nasdaq. The company develops, manufactures More…


By Gali Weinreb On Monday, December 9th, 2013

Lumenis Files to Raise $115 Million on Nasdaq

– The laser surgical devices company plans to hold the IPO in the first quarter of 2014. –   Lumenis Ltd., a developer of lasers for minimally invasive surgical procedures, has filed a prospectus with the More…


By Gali Weinreb On Sunday, November 10th, 2013

Lumenis to Raise $100 Million on Nasdaq

– The medical devices company plans to raise the money at a company valuation of $500 million by February. – – Sources inform ”Globes” that Lumenis Inc. has set a target date of February 14 More…



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.